The fifth edition of this specialized workshop provides an overview of different issues to enhance the preparation of participants. It is focused on both theoretical and practical aspects of health systems and health law exploring current legal and policy issues which impact on the rights and responsibilities of patients, health providers, and policy makers.
The workshop is addressed to participants with different backgrounds such as healthcare practitioners, policy makers, health lawyers, nurses, and other interested people in health systems and patients´ rights.
Seminar is free of charge for the workforce of the public health system and universities of the Cantabria International Campus (Universidad de Cantabria and Universidad Internacional Menéndez Pelayo-UIMP).
Fee waivers for registration and/or scholarships for accommodation can be granted on request from interested people.
Since the seminar will be developed in an interactive way, only a maximum number of 25 participants will be admitted to the workshop.
Program of the course: Get it here.
Link to registration: sign up here.
The fifth edition of this specialized workshop provides an overview of different issues to enhance the preparation of participants. It is focused on both theoretical and practical aspects of health systems and health law exploring current legal and policy issues which impact on the rights and responsibilities of patients, health providers, and policy makers. The […]
Dr. David San Segundo, immunologist of the HUMV Immunology Service and researcher of the IDIVAL Transplant and Autoimmunity group, has been chosen to be part of the ESOT (European Organ Transplantation Society) Basic Science Committee during the congress held in September in Copenhagen.
The Committee is made up of 7 members, with a balanced composition both from a scientific and geographical point of view, and is the platform that leads European professionals working on Basic aspects of transplantation.
The mission of this committee is to promote research and education in the field of transplantation from the most basic aspects, in which Dr. San Segundo has been working since 2004 within the line of the Transplant and Autoimmunity group (@immunoHUMV).
Dr. David San Segundo, immunologist of the HUMV Immunology Service and researcher of the IDIVAL Transplant and Autoimmunity group, has been chosen to be part of the ESOT (European Organ Transplantation Society) Basic Science Committee during the congress held in September in Copenhagen. The Committee is made up of 7 members, with a balanced composition […]
Place: Marqués de Valdecilla University Hospital, Santander. Class of Formation of the Marquesa de Pelayo Library. Pab 16, 2nd floor.
Date: October 8-10, 2019.
Organized by: Dr. Javier Crespo, Dr. María Teresa Arias-Loste, Dr. Paula Iruzubieta.
Endorsed by AEEH and SEPD
Sponsored by GILEAD Sciences.
Thursday, October 10
Place: Marqués de Valdecilla University Hospital, Santander. Class of Formation of the Marquesa de Pelayo Library. Pab 16, 2nd floor. Date: October 8-10, 2019. Organized by: Dr. Javier Crespo, Dr. María Teresa Arias-Loste, Dr. Paula Iruzubieta. Endorsed by AEEH and SEPD Sponsored by GILEAD Sciences. Tuesday, October 8 09:30 – 9:45 Presentation of the course. […]
The Carlos III Health Institute (ISCIII) and the Roche Foundation, have called for a grant to help in training in “Data Science in Personalized and Precision Medicine” to take a master's degree in Health Informatics at the School of Medicine of Cornell University (United States).
To this scholarship, all higher graduates with a Bachelor's Degree in Health Sciences, Engineering or other Degree, who develop their activity in relation to the theme of the call and who belong to assistance and / or research centers of the National Health System may apply, including the Health Research Institutes.
All information about the scholarship, bases and forms, is available on the web https://www.institutoroche.es/premiosybecas/becacienciadedatos and those interested should send the application forms to the email: becacienciadedatos@institutoroche.es until 31 October 2019.
For further questions, you can also contact the email becacienciadedatos@institutoroche.es
The Carlos III Health Institute (ISCIII) and the Roche Foundation, have called for a grant to help in training in “Data Science in Personalized and Precision Medicine” to take a master's degree in Health Informatics at the School of Medicine of Cornell University (United States). To this scholarship, all higher graduates with a Bachelor's Degree in Health Sciences, Engineering […]
The Cognitive Impairment Unit of the Marqués de Valdecilla University Hospital has developed a new and original test for the differential diagnosis of dementias. The study, which has been published in the Journal of Alzheimer's Disease, shows how by carrying out four drawings (turtle, strawberry, envelope and train) the researchers were able to diagnose with high precision the type of dementia suffered by a group of patients.
The project is part of the doctoral thesis of one of the unit's neuropsychologists, Ana Pozueta, which focuses on the study of a particular type of dementia called semantic dementia in which the loss of concepts is the main symptom: “Just as in Alzheimer's disease, recent memory loss is the first thing the family notes, in semantic dementia patients begin to have difficulty understanding the meaning of words and progressively stop knowing what objects are used for. “
The researchers appreciated that this loss of concepts was very characteristic in the drawings made by the patients, which were often very similar to each other and with a tendency towards prototypes: for example “by asking them to draw a duck they did it with four legs, since the prototype animal is the dog and all the drawings resembled this model, and the same happened with other categories of concepts such as vehicles ” (see figure)
The principal investigator of the study, Pascual Sánchez-Juan, says that the idea arose when he saw how the patients' drawings resembled the primitive drawings of young children. “The drawings of patients with semantic dementia reminded me a lot of those made by my 4-year-old daughter, in young children the storage structure of the concepts (semantic memory) is in development, so we decided to study their development in parallel For this, we collected drawings of hundreds of children between 4 and 7 years old who helped us better understand the phases of semantic development, which we observed to be in the opposite direction of the deterioration suffered by patients. All this information helped us to develop a test based on four drawings that is very specific to detect this type of dementia.
The test, called “Brief Drawing task”, is carried out in less than 4 minutes and, despite its simplicity, offers valuable information in the diagnosis of dementia, with the advantage that it does not depend on language, a function that often It is affected in patients with dementia.
The Cognitive Impairment Unit of the Marqués de Valdecilla University Hospital has developed a new and original test for the differential diagnosis of dementias. The study, which has been published in the Journal of Alzheimer's Disease, shows how by carrying out four drawings (turtle, strawberry, envelope and train) the researchers were able to diagnose with […]
The IDIVAL is a member of GEMSTONE, a recently granted COST action. COST actions are projects funded by the European Union with the objective of creating and strengthening international research networks. GEMSTONE (GEnomics of MusculoSkeletal traits TransnatiOnal Network) aims to enhance the investigation of the genetic and genomic factors involved in skeletal diseases and their translation into practice.
Financed with 500,000 Euros, its activity is organized around various work packages (genomic scan analysis, bioinformatics, rare diseases, etc.). In GEMSTONE 24 countries participate and is coordinated by a steering committee of which Dr. José A. Riancho, IDIVAL researcher of the Mineral and Lipid Metabolism Group is part.
The IDIVAL is a member of GEMSTONE, a recently granted COST action. COST actions are projects funded by the European Union with the objective of creating and strengthening international research networks. GEMSTONE (GEnomics of MusculoSkeletal traits TransnatiOnal Network) aims to enhance the investigation of the genetic and genomic factors involved in skeletal diseases and their […]
The Cardiovascular Research group led by Dr. De La Torre has obtained funding from the Carlos III Health Institute in the last call of the recently resolved National Plan.
Coronary heart disease and its consequences are leaders in morbidity and mortality and resource consumption in developed countries like ours. Population aging and longer life expectancy contribute even more to this. The epidemiological impact of these pathologies is growing dramatically in less developed countries.
Patients with coronary heart disease survive acute episodes more, but despite revascularization and pharmacological interventions, many patients in their subsequent evolution suffer serious adverse events such as death, reinfarction, stroke, new exacerbations, hospitalizations and revascularizations. This means lost years of life, quality of life, medical and social resources.
There are risk indices that allow identifying the most at risk groups, although with certain precision limitations. In spite of this, these indices are little used for assistance after discharge, except for studies and records. With this, patient management does not differ much depending on risk levels. This management is passive, citing patients to consultations every 6 – 12 months, and urgently assisting them when they suffer relapses or events, when they do not die.
Remote ambulatory monitoring of high-risk patients can allow early detection of electrocardiographic abnormalities and thus induce medical actions that positively influence their prognosis.
A single-center, prospective, randomized study with a control group designed to evaluate the effectiveness of monitoring after discharge for 12 months of patients will be initiated. High-risk acute coronary syndrome using two different systems: Biomonitor-2 and Kardia Mobile. After information and consent, they will be randomized to a conventional management group or a monitoring group. In the latter, Bimonitor-2 is implanted to all patients and the feasibility of using Kardia Mobile is evaluated, in which case it is educated in its use and facilitated. This system works through an application for Smartphone. We intend to evaluate whether monitoring with these systems improves the prognosis of these patients.
The need to achieve an improvement in the quality of health, in the state of health and well-being of the population, and on the other hand the urgent need to ensure the sustainability of the health system and social services make it necessary to resort to the use of Tele-medicine technologies, already available but very infra studied in clinical settings, especially in our country.
Management adjusted to individual risks and the focus on prediction-prevention of major adverse events is essential, in order to guarantee the efficiency of medical and socio-sanitary actions.
In addition, and not least, the empowerment of patients to the extent of their possibilities (more than we think), which is talked about a lot but that must be endowed with objective meaning and reality, is key to the sustainability of the health system .
The study is framed in this environment. It is about using the potential of electronic-digital technology to improve the follow-up of the most needy patients. To anticipate the clinical events of consequences that are often irreversible and with serious consequences, involve the patient and families in the processes after discharge, which will also have indirect benefits independent of what is evaluated here.
The Cardiovascular Research group led by Dr. De La Torre has obtained funding from the Carlos III Health Institute in the last call of the recently resolved National Plan. Coronary heart disease and its consequences are leaders in morbidity and mortality and resource consumption in developed countries like ours. Population aging and longer life expectancy […]
The deadline for requesting R&D Projects «Research Challenges» and «Knowledge Generation» 2019 until 10/17/2019 opens, with a total budget of € 362,000,000. The objective of the State R&D&i Program Oriented to the Challenges of the Company is to finance the execution of «R&D&i Projects», within the framework of the State Program for the Generation of Knowledge and Scientific and Technological Strengthening of the System of R&D&i and of the State Program of R&D&i Oriented to the Challenges of the Society, of the State Plan of Scientific and Technical Research and of Innovation 2017-2020.
The purpose of this call is to finance the “Knowledge Generation” and “Research Challenges” project modalities of the 2019 call for R&D Projects.
Within the framework of the State Subprogram of Knowledge Generation, of the State Program of Knowledge Generation and Scientific and Technological Strengthening of the R&D System. These are projects without a previously defined thematic orientation, which are motivated by scientific curiosity and whose main objective is the advancement of knowledge, regardless of the time horizon and its scope.
Types of projects: Type A projects (youth) and Type B projects (consolidated groups) are maintained.
More information here
Within the framework of the State R&D Program Oriented to the Challenges of the Society. The projects, such as their applications in later phases of technological development and experimentation, are aimed at solving problems linked to the eight great challenges of society included in the State Plan.
Types of projects: Type A projects (youth) and Type B projects (consolidated groups) are maintained and JIN type projects and RTA type projects are included.
More information here.
The deadline for submitting applications and documents within IDIVAL: will be three business days before the official deadline: 10/14/2019 at 2:00 p.m. It is advisable to inform the National Projects Unit (fondosnacionales@idival.org) in advance of the intention to request a project.
The deadline for requesting R&D Projects «Research Challenges» and «Knowledge Generation» 2019 until 10/17/2019 opens, with a total budget of € 362,000,000. The objective of the State R&D&i Program Oriented to the Challenges of the Company is to finance the execution of «R&D&i Projects», within the framework of the State Program for the Generation of […]
Considering that the generation of scientific knowledge in the field of health sciences, its dissemination and application to the healthcare activity constitutes a key element to achieve progress and improve the living conditions of citizens, GILEAD SCIENCES has been actively developing a policy of promotion and support for the realization of educational programs aimed at the training of health professionals in the therapeutic areas in which the Company is present.
For this, and through the granting of non-refundable monetary contributions intended for its execution, GILEAD SCIENCES intends to promote the realization of programs or activities that result in the training of the healthcare professional by considering that continuous training and investment in education are beneficial for the patients, for the medical community and for society, in general.
The granting of the aid will be carried out through a competitive competition regime based on the objective assessment criteria set out in these rules. The award of the aid will be made in favor of those who have obtained the highest score until the financial resources available for the call are exhausted.
See the bases of the grant here.
Download the application form here.
Considering that the generation of scientific knowledge in the field of health sciences, its dissemination and application to the healthcare activity constitutes a key element to achieve progress and improve the living conditions of citizens, GILEAD SCIENCES has been actively developing a policy of promotion and support for the realization of educational programs aimed at […]
The application period for R&D Projects «Collaboration Challenges» 2019 opens until 10/24/2019, with a total budget of €260,000,000. The objective of the Challenges-Collaboration call is to support experimental development projects in cooperation between companies and research organizations, in order to promote the development of new technologies, the business application of new ideas and techniques, and contribute to the creation of new products and services.
The call for R&D&i Projects «Collaboration Challenges» aims to advance the incorporation of scientific-technical knowledge and results that allow the validation and pre-competitive development of new technologies, products and services, creating the appropriate context that stimulates, In accordance with the priorities established in the Challenges, the generation of a critical mass in R & D & I of an interdisciplinary nature for its application, transfer, search for solutions and generation of results both in the technological and innovation trajectories of companies such as in the market. Likewise, these projects aim to mobilize private investment, generate employment and improve the country's technological balance, as well as strengthen the international leadership capacity of the Spanish System of Science Technology and Innovation and its agents, contributing to improve the competitiveness of the business fabric .
The deadline for submitting applications and documents belonging to IDIVAL: will be three business days before the official closing deadline: 10/21/2019 at 2:00 p.m. It is advisable to inform the National Projects Unit (fondosnacionales@idival.org) in advance of the intention to request a project.
For further information click here.
Download the summary sheet here.
The application period for R&D Projects «Collaboration Challenges» 2019 opens until 10/24/2019, with a total budget of €260,000,000. The objective of the Challenges-Collaboration call is to support experimental development projects in cooperation between companies and research organizations, in order to promote the development of new technologies, the business application of new ideas and techniques, and […]
